Currently he is the contact principal investigator for the Alzheimer Biomarker Consortium – Down Syndrome (ABC-DS), an international effort (funded by the National Institute of Child Health and Human Development and the National Institute on Aging) to follow a cohort of adults with Down syndrome over time to identify early biomarkers that may herald the onset of Alzheimer's disease.